Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History
Rowland & CO Investment Counsel
- $473 Million
- Q2 2025
A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 660 shares of BIO stock, worth $167,026. This represents 0.03% of its overall portfolio holdings.
Number of Shares
660
Previous 668
1.2%
Holding current value
$167,026
Previous $162,000
1.85%
% of portfolio
0.03%
Previous 0.03%
Shares
20 transactions
Others Institutions Holding BIO
# of Institutions
458Shares Held
18.9MCall Options Held
12.7KPut Options Held
14.4K-
Vanguard Group Inc Valley Forge, PA1.91MShares$484 Million0.01% of portfolio
-
First Eagle Investment Management, LLC1.57MShares$396 Million0.8% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$392 Million0.01% of portfolio
-
Veritas Asset Management LLP913KShares$231 Million2.52% of portfolio
-
Dimensional Fund Advisors LP Austin, TX877KShares$222 Million0.05% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $6.23B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...